O
NMTR

OrbiMed’s 9 Meters Biopharma NMTR Stock Holding History

OrbiMed’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-425,286
Closed -$2.22K – 149
2022
Q2 		$2.22K Sell
425,286
-88,508
-17% -$834K 0.04% 129
2022
Q1 		$6.16M Hold
513,794
– – 0.1% 113
2021
Q4 		$10.1M Buy
513,794
+85,495
+20% +$1.91M 0.13% 114
2021
Q3 		$11.1M Hold
428,299
– – 0.12% 122
2021
Q2 		$9.42M Sell
428,299
-857,539
-67% -$21.1M 0.1% 128
2021
Q1 		$30.1M Hold
1,285,838
– – 0.28% 83
2020
Q4 		$22.1M Hold
1,285,838
– – 0.19% 96
2020
Q3 		$20.5M Hold
1,285,838
– – 0.26% 83
2020
Q2 		$14.6M Buy
+1,285,838
New +$14.5M 0.21% 87

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

OrbiMed's NMTR Position: Q3 2022 in Review

OrbiMed sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 425,286 shares — an estimated $2.22K sold.

OrbiMed first reported a position in NMTR in Q2 2020 and held it in 9 quarters. The position peaked at $30.1M in Q1 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • OrbiMed reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • OrbiMed sold 425,286 9 Meters Biopharma shares in Q3 2022, an estimated $2.22K.
  • OrbiMed first reported a position in 9 Meters Biopharma in Q2 2020 and held it in 9 quarters.
  • OrbiMed's 9 Meters Biopharma position peaked at $30.1M in Q1 2021.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on OrbiMed's 13F filing for Q3 2022, filed 14 Nov 2022.